ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,776,657 | -57.2% | 105,258 | -62.3% | 0.00% | -100.0% |
| Q2 2023 | $8,825,489 | +164.3% | 279,111 | +157.5% | 0.00% | – |
| Q1 2023 | $3,339,741 | -12.7% | 108,398 | -12.2% | 0.00% | – |
| Q4 2022 | $3,825,874 | +110.8% | 123,495 | +27.7% | 0.00% | – |
| Q3 2022 | $1,815,000 | +30.1% | 96,705 | +25.4% | 0.00% | – |
| Q2 2022 | $1,395,000 | +9864.3% | 77,143 | +7331.9% | 0.00% | – |
| Q1 2022 | $14,000 | – | 1,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
| PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
| NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
| Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
| Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
| Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
| Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
| Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
| CAXTON CORP | 36,302 | $1,124,640 | 2.87% |